Position in IONS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$88,860,855
-$7,055,954 QoQ
Shares Held
1,120,707
-12.3% QoQ
Ownership
0.674%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 513 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. IONS ranks #26 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in IONS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,860,855 | 1,120,707 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $95,916,809 | 1,277,358 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $100,413,529 | 1,269,290 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $33,957,556 | 519,070 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $10,123,843 | 256,235 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $26,393,740 | 874,834 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $27,569,418 | 788,599 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $32,460,655 | 810,301 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $46,178,583 | 968,917 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $19,199,149 | 442,887 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $10,416,528 | 205,901 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,949,734 | 131,167 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,322,328 | 129,718 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $11,283,831 | 315,720 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $12,178,820 | 322,447 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,056,649 | 295,199 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,067,962 | 325,985 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,185,301 | 139,992 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,024,123 | 132,242 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,741,044 | 141,355 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,587,052 | 340,613 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $106,080,151 | 2,359,434 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $191,380,491 | 3,384,869 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $122,024,364 | 2,571,641 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $137,951,363 | 2,339,745 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $110,672,880 | 2,340,797 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||